Angiologix
Mountain View
About Angiologix
As of October 31, 2011, Angiologix, Inc. was acquired by Everist Genomics. Angiologix, Inc., a medical diagnostic device company, provides cardiovascular diagnostic products. Its products are used as tools for accurate, non-invasive, and point-of-care testing of endothelial dysfunction. The company’s diagnostic products are also used in physicians' practices for diagnosing cardiovascular diseases, and for monitoring the effectiveness of cardiovascular therapies. It serves physician-specialists, cardiologists, vascular medicine specialists, endocrinologists, and primary care physicians. Angiologix, Inc. was founded in 2007 and is based in Mountain View, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.8M
- Funding stage: M&A
- Last round: Series Unknown (Jul 2010)
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical
Canonical: https://fsome.com/organization/angiologix-1000625 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.